[HTML][HTML] Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe, PJ Svensson - Thrombosis journal, 2014 - Springer
Introduction In clinical trials new oral anticoagulants (NOAC) have proved to be as effective
as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate …

[PDF][PDF] Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe, PJ Svensson - 2014 - cyberleninka.org
Introduction: In clinical trials new oral anticoagulants (NOAC) have proved to be as effective
as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate …

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe, PJ Svensson - Thrombosis journal, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction In clinical trials new oral anticoagulants (NOAC) have proved to be as effective
as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate …

[PDF][PDF] Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe, PJ Svensson - 2014 - researchgate.net
Introduction: In clinical trials new oral anticoagulants (NOAC) have proved to be as effective
as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate …

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

A Labaf, M Carlwe, P Svensson - Thrombosis Journal, 2014 - lup.lub.lu.se
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in
Sweden. | Lund University Publications Skip to main content LUND UNIVERSITY | LUND …

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe, PJ Svensson - Thrombosis Journal, 2014 - search.proquest.com
Introduction: In clinical trials new oral anticoagulants (NOAC) have proved to be as effective
as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate …

[PDF][PDF] Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe, PJ Svensson - 2014 - core.ac.uk
Introduction: In clinical trials new oral anticoagulants (NOAC) have proved to be as effective
as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate …

Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

A Labaf, M Carlwe, P Svensson - Thrombosis Journal, 2014 - portal.research.lu.se
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in
Sweden Page 1 Efficacy and safety of novel oral anticoagulants in clinical practice: a report …

[HTML][HTML] Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden

A Labaf, M Carlwe… - Thrombosis …, 2014 - thrombosisjournal.biomedcentral …
In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin
for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy …

[引用][C] Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

A Labaf, P Svensson - Thrombosis Journal - lunduniversity.lu.se
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in
Sweden. | Lund University Skip to main content Current students New students Student services …